key: cord-0914078-3bgji4m9 authors: D’Ambrosi, Francesco; Rossi, Gabriele; Soldavini, Chiara Maria; Maggi, Valeria; Cetera, Giulia Emily; Carbone, Ilma Floriana; Di Martino, Daniela; Di Maso, Matteo; Ferrazzi, Enrico title: Management of gestational diabetes in women with a concurrent severe acute respiratory syndrome coronavirus 2 infection, experience of a single center in Northern Italy date: 2020-12-12 journal: Int J Gynaecol Obstet DOI: 10.1002/ijgo.13434 sha: c024efc40b0f6e3037bd74b4e4fceffc1cec4e34 doc_id: 914078 cord_uid: 3bgji4m9 OBJECTIVE: In this study we describe the management of women with gestational diabetes (GD) and an ongoing severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. The aim of the study is to evaluate whether coronavirus disease 2019 (COVID‐19) can further complicate pregnancies, and if the protocol we usually use for GD pregnancies is also applicable to patients who have contracted a SARS‐CoV‐2 infection. METHODS: This is a retrospective study analyzing all pregnant women with GD and concomitant COVID‐19 admitted to our institution for antenatal care between March 1 and April 30, 2020. RESULTS: Among pregnant women with GD and a concomitant SARS‐CoV‐2 infection, the mean age was 32.9 (SD 5.6) years. Two patients (33%) were of white racial origin and four (67%) were of non‐white racial origin. All patients were diagnosed with COVID‐19 during the third trimester of pregnancy. Two women were asymptomatic and four were symptomatic. Only two (33.3%) women received treatment with insulin. None of the patients required intensive care or mechanical ventilation. No complications were found among the neonates. CONCLUSION: COVID‐19 was not found to worsen the prognosis of patients with GD or of their offspring. Glycemic monitoring, diet therapy, and insulin, when needed, are sufficient for good metabolic control and favorable maternal and fetal outcomes. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has had a profound impact on health services worldwide, including antenatal care. In northern Italy, one of the first areas in Europe to be hit by the pandemic, the virus has spread significantly among the pregnant population. 1 Repercussions on prenatal care, especially of high-risk pregnancies, are yet to be analyzed. [1] [2] [3] Among women with high-risk pregnancies, those with gestational diabetes (GD) represent one of the largest subgroups. 4, 5 The prevalence of GD is estimated at around 18% of pregnancies. 4 As far as its repercussions on pregnancy are concerned, GD increases the risk of maternal and perinatal complications, both in the short-term and in the long-term, including a higher prevalence of type 2 diabetes in mothers, and a greater likelihood of childhood obesity in the offspring. 4, 5 As of 2020, coronavirus disease 2019 (COVID-19) can be classified as a complication of pregnancy, especially in women with comorbidities such as GD. [4] [5] [6] [7] [8] In this study we provide a detailed description of the management of pregnant women with GD and an ongoing SARS-CoV-2 infection who gave birth in our obstetric unit, the largest high-risk maternity unit in the metropolitan area of Milan, Italy. This retrospective single-center study was carried out in our Institution Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy, one of the six COVID-19 maternity hubs designated by the Regional Health Authority, between March 1 and April 30, 2020. 9 All pregnant women with GD and concomitant COVID-19 admitted to our institution for prenatal care were eligible for the present study. SARS-CoV-2 infection was diagnosed using a nasopharyngeal swab, which, in accordance with the Italian National Guidelines, 9 is administered to all women, both symptomatic and asymptomatic, at the time of admission. Screening for GD was carried out according to the International Association of Diabetes and Pregnancy Study Groups' recommendations. 8 During the first trimester, fasting plasma glucose was mea- Incidence of COVID-19 was not greater among the GD population. Moreover, the infection was not found to worsen the prognosis of patients with GD or their offspring. None of the women with GD and a concomitant SARS-CoV-2 infection required hospitalization in an intensive care unit or mechanical ventilation. Monitoring of glycemic control and fetal growth according to the protocols of our Institution prevented the onset of pregnancy complications. A possible limitation of the present analysis may be represented by the small number of cases analyzed. We expect to increase our study sample in the following months and to provide further results. The main strength of this study is that it was conducted in one of the six reference centers for the treatment of COVID-19 in women in Lombardy, the first region to be affected by the disease in Europe and one of the areas with the highest diffusion rates of infection. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] In conclusion, glycemic monitoring, diet therapy, and insulin, when needed, are sufficient for obtaining good metabolic control and a favorable maternal and fetal outcomes even among women with GD and a concomitant SARS-CoV-2 infection. The authors have no conflicts of interest. All authors contributed significantly to the conception, planning, performance and analysis of the study. FD, GR, and EF were the primary writers of the manuscript. All authors read, revised, and consented to the publication of the final manuscript. Vaginal delivery in SARS-CoV-2-infected pregnant women in Northern Italy: a retrospective analysis Endocrinology in time of Covid-19: Diagnosis and management of gestational diabetes mellitus Clinical features and outcomes of pregnant women with COVID-19: a systematic review and meta-analysis The impact of adoption of the International Association of Diabetes in Pregnancy Study Group criteria for the screening and diagnosis of gestational diabetes Ultrasound assessment of maternal adipose tissue during 1st trimester screening for aneuploidies and risk of developing gestational diabetes Slowing down the covid-19 outbreak: changing behaviour by understanding it Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy Circolare del Ministero della salute 9 marzo 2020. COVID-19. Aggiornamento della definizione di caso Adequate timing of fetal ultrasound to guide metabolic therapy in mild gestational diabetes mellitus. Results from a randomized study